Exelixis, Inc. (NASDAQ:EXEL) Q1 2024 Earnings Call Transcript

Exelixis, Inc. misses on earnings expectations. Reported EPS is $0.17 EPS, expectations were $0.28.

Related Keywords

United States ,America ,Varant Shirvanian ,Michael Schmidt ,Amy Peterson ,Mike Morrissey ,Peter Lamb ,Chris Senner ,Neeraj Agarwal ,Christopher Senner ,Dana Aftab ,Michael Morrissey ,Monty Pal ,Jennifer Chan ,Joe Catanzaro ,Jason Gerberry ,Laura Dillard ,Cabo Atezo ,Joseph Catanzaro ,Broad Institute ,Alliance For Clinical Trials In Oncology ,Nasdaq ,Exelixis Inc ,Fastest Growing Fintech Companies ,Exchange Commission ,Call Transcript April ,Exelixis First Quarter ,Results Conference ,Chief Financial Officer ,Executive Vice President ,Chief Medical Officer ,Chief Scientific Officer ,Risk Factors ,Clinical Trials ,Scientific Strategy ,Human Resources ,Highest Suicide Rates ,